 GUANGZHOU, China, Oct. 25, 2022 GLOBE NEWSWIRE -- Burning Rock Biotech Limited NASDAQ: BNR, the Company or Burning Rock, a company focused on the application of next generation sequencing NGS technology in the field of precision oncology, today announced that it plans to release its unaudited financial results for the third quarter of 2022 before the U.S. market opens on November 16, 2022. Following the release, company management will host a conference call at 8:30 a.m. ET 9:30 p.m. Hong Kong time on the same day to discuss its financial results for the third quarter of 2022. 